Physician profile
Wei Tian
NPI 1245492784
$1,557.66
in general payments reported to CMS, 2019-2025
7 companies · $68.05 in 2025
The $68.05 reported for 2025 was more than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2021: $1,000 · 2022: $144 · 2023: $25.96 · 2024: $180 · 2025: $68.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $1,000.00 | 2021 | |
| Stryker Corporation | $180.45 | 2024 | Citrefix, Ortholoc 3di |
| Smith+Nephew, INC. | $144.16 | 2022 | |
| Abbott Laboratories | $139.04 | 2019 | |
| Dompe US, INC. | $52.03 | 2025 | Oxervate |
| Medtronic, INC. | $25.96 | 2023 | Intellis Adaptivestim |
| Kerecis Limited | $16.02 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Tian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.